ADVERTISEMENT
search.svg

Pharmacy News

FDA approves higher dosage of naloxone nasal spray

On April 30, FDA announced the approval of a higher dosage of naloxone hydrochloride nasal spray (Kloxxado—Hikma Pharmaceuticals) to treat opioid overdose. The newly approved product delivers 8 mg of naloxone into the nasal cavity, compared with previously approved 2- and 4-mg naloxone nasal spray products.

FDA revokes bamlanivimab authorization

FDA said on April 16 that it is revoking the emergency use authorization (EUA) for bamlanivimab—when administered alone—to be used for treatment of mild to moderate COVID-19 in adults and certain pediatric patients. 

How to talk to patients about the J&J vaccine

Patients will be coming to pharmacists with questions and concerns as the recommendation to suspend use of the Janssen (Johnson & Johnson, J&J) vaccine remains in place.

RSS